Cardiology Trials
di Cardiology Trials
Ultimo episodio
Summary and discussion SHAM-PVI, PFA-SHAM and PVI-SHAM-AF
Summary and discussion SHAM-PVI, PFA-SHAM and PVI-SHAM-AF
Informazioni su questo podcast
An exploration of pivotal clinical trials in cardiovascular medicine that have significantly influenced the field. This podcast aligns with our publications on the Cardiology Trial's Substack.
cardiologytrials.substack.com
Episodi
I 20 episodi più recenti su 149
- Summary and discussion SHAM-PVI, PFA-SHAM and PVI-SHAM-AF · 37 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of CASTLE-AF and CASTLE-HTx · 41 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of CABANA and EARLY-AF · 43 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of EAST-AFNET 4 · 1 h 0 minFor full review of the trial, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of ANDROMEDA, ATHENA and PALLAS · 31 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of SAFE-T and RACE II · 41 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of AFFIRM and RACE · 45 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Special episode (ACC 2026: CHAMPION-AF, HI-PEITHO) · 52 minThis is the article John referenced that discusses Watchman https://www.heartrhythmjournal.com/article/S1547-5271(17)31200-6/abstract Get full access to Cardiology Trial’s…
- Summary and discussion of VICTORIA and VICTOR · 34 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of DAPA-HF and EMPEROR-Reduced · 39 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Special episode (AHA 2025: OCEAN, ADAPT AF-DES) · 47 minGet full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Special episode (AHA 2025: VESALIUS-CV, DECAF) · 41 minGet full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Summary and discussion of PARADIGM-HF and PIONEER-HF · 36 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Special episode (ESC 2025: AQUATIC, VICTOR) · 50 minGet full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Special episode (ESC 2025: REBOOT-CNIC, BETAMI-DANBLOCK, DIGIT-HF) · 41 minDiscussion of landmark trials presented at the European Society of Cardiology (ESC) congress 2025 Get full access to Cardiology Trial’s Substack at…
- Summary and discussion of BEST and SENIORS · 32 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Review of the A-HeFT trial · 9 minN Engl J Med 2004;351:2049-2057 Background: Endothelial dysfunction, reduced nitric oxide availability, and increased oxidative stress occur in patients with heart failure and…
- Review of the CHARM-Alternative trial · 10 minTHE LANCET 2003;362:772-776 Background: Angiotensin converting enzyme inhibitors (ACEi) reduce mortality and morbidity in patients with systolic heart failure (see CONSENSUS and…
- Summary and discussion of Carvedilol Prospective Randomized Cumulative Survival Study, Val-HeFT, CHARM-Added and CIBIS-II · 57 minFor full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
- Review of the CIBIS-II Trial · 5 minThe Lancet Volume 353, Issue 9146 p9-13 January 02, 1999 Background: Accumulating data at the time suggested functional benefits of antagonism of beta-adrenoreceptors in patients…







